Autogenous Vaccine Market
Autogenous Vaccine Market Study by Bacterial Strain and Virus Strain for Veterinary Research Institutes, Livestock Farming Companies, and Veterinary Clinics & Hospitals from 2024 to 2034
Analysis of Autogenous Vaccine Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Autogenous Vaccine Market Outlook (2024 to 2034)
As per Fact.MR’s new market research report, the global autogenous vaccine market is estimated to be valued at US$ 144.8 million in 2024. Worldwide demand for autogenous vaccines is forecasted to increase at 5.5% CAGR and reach a market value of US$ 246.8 million by the end of 2034.
Autogenous vaccines are specially developed to address some particular pathogens or diseases present within a certain animal group or in a particular region. There is a growing demand for customized solutions to address diseases, which are not efficiently covered through conventional vaccines. Further, increasing awareness about the importance of animal welfare and health among veterinarians, regulatory bodies, and farmers is projected to generate requirements for tailored and effective solutions to combat different diseases affecting animals.
Significant expansion of the livestock sector is forecasted to boost demand for autogenous vaccines. With increasing demand for animal-derived products, there is a parallel requirement to ensure the well-being and health of livestock, which is generating demand for customized vaccines. Increasing regulatory pressure and concerns about antibiotic resistance to minimize their use in livestock are projected to lead to rising interest in alternative strategies for disease management, which include vaccines as a safer option.
- Demand for autogenous vaccines in China is forecasted to increase at 4.3% CAGR and reach a valuation of US$ 5 million by the end of 2034.
- North America is projected to account for 34.8% of the global autogenous vaccine market share by 2034.
- Livestock farming companies are forecasted to account for 45.3% share of global market revenue by 2034.
Regulatory bodies in many countries are forecasted to show support and flexibility for the approval of autogenous vaccines owing to an increasing understanding of their importance in addressing specific diseases in animals. Furthermore, outbreaks of animal diseases, particularly with economic impacts, are projected to increase the requirements for targeted and rapid responses, therefore positively contributing to the expansion of the autogenous vaccine market size.
| Report Attributes | Details |
|---|---|
| Autogenous Vaccine Market Size (2024E) | US$ 144.8 Million |
| Forecasted Market Value (2034F) | US$ 246.8 Million |
| Global Market Growth Rate (2024 to 2034) | 5.5% CAGR |
| United States Market Share (2034F) | 93.6% |
| Bacteria Strains Segment Market Share (2034F) | 71% |
| Mexico Market Growth Rate (2024 to 2034) | 4.6% CAGR |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Key Factors are Positively Influencing Autogenous Vaccine Market Growth?
“Growing Demand for Autogenous Vaccines for Livestock Management”
In recent times, there has been a growing demand to enhance animal husbandry practices. In addition, growing emphasis is given to minimizing the use of antibiotics for the treatment of sick herds or animals with increasing public interest in animal health and welfare. Further, many developed countries are emphasizing minimizing the use of antibiotics to reduce animal loss.
Owing to the limited availability of some veterinary medicines, it is difficult to manage health issues for some species, especially minor ones such as the turkey. Thus, demand for accessible products, such as autogenous vaccines, is projected to rise in the coming 10 years.
“Focus on Production of Customized Autogenous Vaccines”
Encountering constant changes and evolution in reoviruses is common. Various serotypes are harmful to the health and performance of poultry. Therefore, several manufacturers are emphasizing the production of customized autogenous poultry reovirus vaccines. Farm-specific setups are included in these vaccines to ensure a close match for the constantly changing environment of the farms. Autogenous vaccinations are recognized as an efficient approach to addressing antigenic changes in the fields.
For instance :
- In April 2020, Phibro Animal Health Company added antigen combinations to its available range of autogenous vaccines. These customized and advanced vaccines are projected to assist poultry farmers in protecting their animals against several infectious diseases.
What are Market Players Focusing on to Remain Competitive?
“Stringent Regulatory Framework for Production and Export of Vaccines”
Autogenous vaccines are specialized vaccinations, which are produced from antigens. Therefore, a licensed facility is pivotal in this regard. In addition, there are differences in the regulatory laws among countries. Every country has its license regulations and requirements for vaccine production. Therefore, an absence of set uniform regulations is projected to adversely impact autogenous vaccine market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Why are Startups Invest in This Business?
“Production of Customized Vaccines Leveraging Advancements in Biotechnology”
Advancements taking place in molecular biology and biotechnology are estimated to facilitate the development of more efficient autogenous vaccines. Several techniques, including proteomics, bioinformatics, and genomics are forecasted to play a pivotal role in the development and production of these customized vaccines, which are further projected to attract startups to invest in the market.
Country-wise Insights
North America is forecasted to hold 34.8% of the global market share by 2034 owing to the rising incidences of livestock-related diseases, including otitis externa, sinusitis, pharyngitis, and dermatitis. Further, the growing use of customized vaccines to treat these diseases is projected to contribute to autogenous vaccine market trends.
Why is the United States Garnering the Attention of Players?
“Supportive Government Initiatives for Veterinary Care”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 50 Million |
| Growth Rate (2024 to 2034) | 4.9% CAGR |
| Projected Value (2034F) | US$ 80 Million |
The United States is forecasted to hold 93.6% share of the North American market by 2034. Farmers in the United States are made aware of the impact of livestock diseases along with their preventive measures through government programs and initiatives.
Public health officials, manufacturers, the USDA’s ARS (Animal Research Service), etc., work together for conducting surveillance programs for advancing scientific studies to address issues of public and veterinary health. These campaigns are projected to increase awareness about animal health, therefore contributing to the rising demand for autogenous vaccines.
Why are Suppliers of Autogenous Vaccines Interested in China?
“Increasing Use of Animal Vaccines amid Rising Incidence of Livestock-Related Diseases”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 4 Million |
| Growth Rate (2024 to 2034) | 4.3% CAGR |
| Projected Value (2034F) | US$ 5 Million |
China is projected to occupy 89.4% share of the East Asia market by 2034. Increasing incidences of livestock-related diseases in the country along with the growing use of animal vaccines is forecasted to positively impact consumption of autogenous vaccines, therefore contributing to market growth.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Fact.MR, through its newly published study, asserts that traction for bacterial strains is projected to increase further owing to their higher stability cultures in incubators and in vitro labs. In addition, the built-in adjuvant qualities of these strains are also projected to contribute to their increased demand.
Which Type of Autogenous Vaccines are Preferred for Livestock Disease Management?
“Widespread Adoption of Bacterial Vaccines Due to More Efficient Oral Administration Options”
| Attribute | Bacterial Strain |
|---|---|
| Segment Value (2024E) | US$ 98.7 Million |
| Growth Rate (2024 to 2034) | 5.9% CAGR |
| Projected Value (2034F) | US$ 175.2 Million |
Bacterial strains are projected to hold 71% share of the global market by 2034, as per the research analysis published by Fact.MR, a market research and competitive intelligence provider. Live bacterial vaccines offer multiple benefits, including built-in adjuvant qualities, the ability to replace real infection, and more efficient oral administration options. Thus, these benefits are projected to generate demand for bacterial strains for the development of customized autogenous vaccines.
What is the Contribution of Livestock Farming Companies to the Global Market?
“High Demand for Animal Products Driving Substantial Autogenous Vaccine Use by Livestock Companies”
| Attribute | Livestock Farming Companies |
|---|---|
| Segment Value (2024E) | US$ 68.8 Million |
| Growth Rate (2024 to 2034) | 5% CAGR |
| Projected Value (2034F) | US$ 111.8 Million |
Livestock farming companies are forecasted to account for 45.3% share of global market revenue by 2034, according to the analysis published by Fact.MR. The livestock sector is very active around the world. Significant transformations in the livestock sector in potentially high-growth markets are attributed to the increasing demand for various types of animal products. Growing urbanization, income, and human population are projected to increase the consumption of livestock products, thus driving market growth.
Competitive Landscape
Presence of regional and global players is making the market highly competitive. Market players are emphasizing inorganic expansion as one of the prominent growth strategies to maintain competitiveness. Expenditures for the strengthening of the supply chain management system, offering quality products, new developments, etc., are set to help companies secure their position. In addition, participants are also working to increase their reach across regions through acquisitions, mergers, etc.
For instance :
- Ceva Sante Animale, in September 2020, tripled its capability for autogenous vaccine production at its French facility.
Key players in the autogenous vaccine market are Newport Laboratories, Inc., Ceva, Elanco Animal Health, ACE Laboratory Services, AniCon Labor GmbH, Huvepharma, Inc., Cambridge Technologies, Dyntec s. r. o., Vaxxinova, Hygieia Biological Laboratories, Sanphar, Addison Biological Laboratory, Kennebec River Biosciences, and Barramundi Asia Pte Ltd.
Segmentation of Autogenous Vaccine Market Research
-
By Product Type :
- Bacterial Strain
- Virus Strain
-
By End User :
- Veterinary Research Institutes
- Livestock Farming Companies
- Veterinary Clinics & Hospitals
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product Type launches 5.2.2. Cost of Product Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product Type 6.4.2. Revenue By End User 6.4.3. Revenue By Country 6.5. 2023 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034 7.1. Historical Market Volume (Units) Analysis, 2018 to 2023 7.2. Current and Future Market Volume (Units) Projections, 2024 to 2034 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034 9.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 9.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2018 to 2023 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024 to 2034 10.3.1. Bacterial Strain 10.3.2. Virus Strain 10.4. Market Attractiveness Analysis By Product Type 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 to 2023 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024 to 2034 11.3.1. Veterinary Research Institutes 11.3.2. Livestock Farming Companies 11.3.3. Veterinary Clinics & Hospitals 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2023 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product Type 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product Type 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product Type 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product Type 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Product Type 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product Type 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Product Type 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Product Type 20.2.2. By End User 20.3. Canada Market Analysis 20.3.1. By Product Type 20.3.2. By End User 20.4. Mexico Market Analysis 20.4.1. By Product Type 20.4.2. By End User 20.5. Brazil Market Analysis 20.5.1. By Product Type 20.5.2. By End User 20.6. U.K. Market Analysis 20.6.1. By Product Type 20.6.2. By End User 20.7. Germany Market Analysis 20.7.1. By Product Type 20.7.2. By End User 20.8. France Market Analysis 20.8.1. By Product Type 20.8.2. By End User 20.9. Italy Market Analysis 20.9.1. By Product Type 20.9.2. By End User 20.10. Spain Market Analysis 20.10.1. By Product Type 20.10.2. By End User 20.11. BENELUX Market Analysis 20.11.1. By Product Type 20.11.2. By End User 20.12. Russia Market Analysis 20.12.1. By Product Type 20.12.2. By End User 20.13. China Market Analysis 20.13.1. By Product Type 20.13.2. By End User 20.14. Japan Market Analysis 20.14.1. By Product Type 20.14.2. By End User 20.15. South Korea Market Analysis 20.15.1. By Product Type 20.15.2. By End User 20.16. India Market Analysis 20.16.1. By Product Type 20.16.2. By End User 20.17. ASEAN Market Analysis 20.17.1. By Product Type 20.17.2. By End User 20.18. Australia Market Analysis 20.18.1. By Product Type 20.18.2. By End User 20.19. New Zealand Market Analysis 20.19.1. By Product Type 20.19.2. By End User 20.20. GCC Countries Market Analysis 20.20.1. By Product Type 20.20.2. By End User 20.21. Turkey Market Analysis 20.21.1. By Product Type 20.21.2. By End User 20.22. South Africa Market Analysis 20.22.1. By Product Type 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Newport Laboratories, Inc. 22.3.1.1. Overview 22.3.1.2. Product Type Portfolio 22.3.1.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Ceva 22.3.2.1. Overview 22.3.2.2. Product Type Portfolio 22.3.2.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Elanco Animal Health 22.3.3.1. Overview 22.3.3.2. Product Type Portfolio 22.3.3.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. ACE Laboratory Services 22.3.4.1. Overview 22.3.4.2. Product Type Portfolio 22.3.4.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. AniCon Labor GmbH 22.3.5.1. Overview 22.3.5.2. Product Type Portfolio 22.3.5.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Huvepharma, Inc. 22.3.6.1. Overview 22.3.6.2. Product Type Portfolio 22.3.6.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Cambridge Technologies 22.3.7.1. Overview 22.3.7.2. Product Type Portfolio 22.3.7.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Dyntec s. r. o. 22.3.8.1. Overview 22.3.8.2. Product Type Portfolio 22.3.8.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Vaxxinova 22.3.9.1. Overview 22.3.9.2. Product Type Portfolio 22.3.9.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Hygieia Biological Laboratories 22.3.10.1. Overview 22.3.10.2. Product Type Portfolio 22.3.10.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Sanphar 22.3.11.1. Overview 22.3.11.2. Product Type Portfolio 22.3.11.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Addison Biological Laboratory 22.3.12.1. Overview 22.3.12.2. Product Type Portfolio 22.3.12.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Kennebec River Biosciences 22.3.13.1. Overview 22.3.13.2. Product Type Portfolio 22.3.13.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. Barramundi Asia Pte Ltd. 22.3.14.1. Overview 22.3.14.2. Product Type Portfolio 22.3.14.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Product Type, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By End User, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Product Type, 2024 (E)
Figure 18: North America Market Value Share, By End User, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Product Type, 2024 (E)
Figure 26: Latin America Market Value Share, By End User, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Product Type, 2024 (E)
Figure 34: Europe Market Value Share, By End User, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Product Type, 2024 (E)
Figure 42: South Asia Market Value Share, By End User, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Product Type, 2024 (E)
Figure 50: East Asia Market Value Share, By End User, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Product Type, 2024 (E)
Figure 58: Oceania Market Value Share, By End User, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Product Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Product Type, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By End User, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Product Type, 2024 (E)
Figure 78: Canada Market Value Share, By End User, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Product Type, 2024 (E)
Figure 81: Mexico Market Value Share, By End User, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Product Type, 2024 (E)
Figure 84: Brazil Market Value Share, By End User, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Product Type, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By End User, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Product Type, 2024 (E)
Figure 90: Germany Market Value Share, By End User, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Product Type, 2024 (E)
Figure 93: France Market Value Share, By End User, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Product Type, 2024 (E)
Figure 96: Italy Market Value Share, By End User, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Product Type, 2024 (E)
Figure 99: Spain Market Value Share, By End User, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Product Type, 2024 (E)
Figure 102: Russia Market Value Share, By End User, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Product Type, 2024 (E)
Figure 105: China Market Value Share, By End User, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Product Type, 2024 (E)
Figure 108: Japan Market Value Share, By End User, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Product Type, 2024 (E)
Figure 111: South Korea Market Value Share, By End User, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Product Type, 2024 (E)
Figure 114: India Market Value Share, By End User, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Product Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By End User, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Product Type, 2024 (E)
Figure 120: Australia Market Value Share, By End User, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Product Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By End User, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Product Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Product Type, 2024 (E)
Figure 129: Turkey Market Value Share, By End User, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Product Type, 2024 (E)
Figure 132: South Africa Market Value Share, By End User, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the valuation of the autogenous vaccine market in 2024?
The global autogenous vaccine market is estimated at US$ 144.8 million in 2024.
What is the sales projection for autogenous vaccines for 2034?
Sales of autogenous vaccines are projected to reach US$ 246.8 million by the end of 2034.
At what rate is the demand for autogenous vaccines projected to grow?
Demand for autologous vaccines is forecasted to increase at 5.5% CAGR from 2024 to 2034.
How much share of the global market is North America projected to account for?
North America is projected to hold 34.8% share of global market revenue by 2034.
At what rate are the sales of autogenous vaccines forecasted to rise in Mexico?
Sales of autogenous vaccines in Mexico are forecasted to increase at a CAGR of 4.6% from 2024 to 2034.
What is an autogenous vaccine for humans?
Autogenous vaccines are used to treat chronic infections, including respiratory tract infections, skin infections, urinary tract infections, and colon infections.
Autogenous Vaccine Market